ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Causal relationship between circadian rhythm-related genes expression and spinal disorders: systematic druggable genome-wide Mendelian randomization analysis and virtual screening.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To systematically investigate the causal relationships between circadian rhythm-related genes and the pathogenesis of six spinal disorders (scoliosis, spinal osteochondrosis, instability, stenosis, spondylosis, and spondyloarthritis) using an integrated bioinformatics framework. Mendelian randomization and Bayesian colocalization were applied to cis-eQTL data and GWAS summary statistics. Functional enrichment, protein-protein interaction network analysis, drug prediction, and structure-based virtual screening were subsequently performed. Our research identified 16 potential circadian genes, with four (KAT5, EZH2, BMP2, and EDN1) showing moderate to strong colocalization evidence across multiple disorders. Pathway enrichment highlighted relaxin signaling and longevity regulation. Drug prediction and molecular docking nominated Simvastatin, Niacin, and Acid Red 87 as high affinity candidate compounds. This study establishes causal links between circadian gene dysregulation and spinal diseases, pinpoints key genes and pathways, and proposes potential small-molecule therapeutics for experimental validation.
Indexed as
Identifiers
41526531What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.